Novo Nordisk A/S (NVO) SEC Filings & 10K Form

→ Don’t expose yourself to stocks during the week (From DTI) (Ad)

Free nvo Stock Alerts

$124.53

+1.08 (+0.87%)

(As of 04/17/2024 ET)

Compare

Recent Novo Nordisk A/S SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
04/08/2024 10:09 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/02/2024 7:02 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/01/2024 12:00 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/25/2024 9:46 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/21/2024 11:13 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/18/2024 9:58 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/11/2024 12:14 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
Get the Latest News and Ratings for NVO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter.
03/08/2024 1:53 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/05/2024 7:29 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/04/2024 9:50 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/26/2024 5:38 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/22/2024 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/22/2024 5:06 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/14/2024 7:06 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/13/2024 1:24 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/12/2024 8:18 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/09/2024 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/07/2024 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/06/2024 2:14 PM	BlackRock Inc. (Filed by) Novo Nordisk A/S (Subject)	Form SC 13G/A
02/06/2024 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/05/2024 5:57 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/02/2024 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/31/2024 6:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/31/2024 5:51 AM	Novo Nordisk A/S (Filer)	Form 20-F Registration statement / Annual report / Transition report
01/31/2024 5:55 AM	Novo Nordisk A/S (Filer)	Form IRANNOTICE
01/31/2024 5:27 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/30/2024 11:21 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/22/2024 9:32 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/16/2024 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/11/2024 9:34 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/08/2024 7:38 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/08/2024 7:19 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/22/2023 7:29 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/19/2023 9:51 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/11/2023 8:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/28/2023 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/21/2023 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/13/2023 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/07/2023 11:54 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/07/2023 5:12 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/06/2023 3:39 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
Claim Your Complimentary Bitcoin Reward (Ad) Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now
11/06/2023 3:39 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/06/2023 8:28 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/03/2023 10:35 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/02/2023 6:27 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/01/2023 11:44 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/23/2023 8:29 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/16/2023 8:13 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/16/2023 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/11/2023 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/10/2023 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/02/2023 7:52 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/26/2023 9:49 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/18/2023 8:28 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/13/2023 11:15 PM	Novo Nordisk A/S (Filer)	Form EFFECT
09/13/2023 2:33 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/13/2023 5:18 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/05/2023 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/28/2023 9:38 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/22/2023 12:40 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/18/2023 8:04 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/11/2023 9:21 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/10/2023 5:27 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/09/2023 8:21 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/08/2023 7:09 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/31/2023 9:03 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/24/2023 8:50 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/17/2023 8:45 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/17/2023 8:45 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/10/2023 9:07 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/03/2023 7:48 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/27/2023 2:55 PM	Novo Nordisk A/S (Filer)	Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)
06/27/2023 2:56 PM	Novo Nordisk A/S (Filer)	Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)
06/26/2023 9:50 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/21/2023 5:06 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/12/2023 6:31 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/06/2023 5:50 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/30/2023 9:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/30/2023 9:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/23/2023 7:09 AM	Novo Nordisk A/S (Filer)	Form SD Specialized Disclosure Report
05/23/2023 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/16/2023 7:11 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/16/2023 7:12 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/16/2023 7:14 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/10/2023 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/10/2023 5:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/10/2023 5:02 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/09/2023 10:33 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/04/2023 5:58 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/03/2023 7:50 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/28/2023 7:39 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
Claim Your Complimentary Bitcoin Reward (Ad) Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now
04/26/2023 8:06 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/26/2023 8:08 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/26/2023 8:08 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies:

SEC Filings Tools:

This page (NYSE:NVO) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Novo Nordisk A/S (NVO) SEC Filings & 10K Form

Recent Novo Nordisk A/S SEC Filings

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info